Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool

NCT05407168 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT05407168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05407168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool
Lead sponsor
OHSU Knight Cancer Institute
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 31, 2022
Completion date
December 31, 2027
Enrollment
237 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

lung carcinoma